T2 Biosystems Inc. (NASDAQ: TTOO)
$0.8900
-0.0600 ( -6.32% ) 265.4K
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Market Data
Open
$0.8900
Previous close
$0.9500
Volume
265.4K
Market cap
$15.56M
Day range
$0.8850 - $0.9650
52 week range
$0.8850 - $8.3799
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4/a | Other | 1 | Nov 28, 2023 |
8-k/a | 8K-related | 12 | Nov 24, 2023 |
nt | Quarterly Reports | 1 | Nov 15, 2023 |
10-q | Quarterly Reports | 83 | Nov 15, 2023 |
8-k | 8K-related | 12 | Nov 01, 2023 |
8-k | 8K-related | 14 | Oct 25, 2023 |
8-k | 8K-related | 12 | Oct 23, 2023 |
4 | Insider transactions | 1 | Oct 20, 2023 |
8-k | 8K-related | 13 | Oct 17, 2023 |
8-k | 8K-related | 16 | Oct 12, 2023 |